MedX Health Corp (CVE:MDX – Get Free Report)’s share price fell 6.3% during trading on Thursday . The stock traded as low as C$0.08 and last traded at C$0.08. 425,166 shares were traded during trading, an increase of 223% from the average session volume of 131,807 shares. The stock had previously closed at C$0.08.
MedX Health Stock Performance
The firm has a market cap of C$20.26 million, a price-to-earnings ratio of -3.75 and a beta of 1.26. The stock’s fifty day moving average is C$0.06 and its two-hundred day moving average is C$0.06.
About MedX Health
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market.
Featured Stories
- Five stocks we like better than MedX Health
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- There Are Different Types of Stock To Invest In
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- 3 Fintech Stocks With Good 2021 Prospects
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for MedX Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedX Health and related companies with MarketBeat.com's FREE daily email newsletter.
